Evidence
Document this CPD
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Diagnosis of Liver Cirrhosis and Liver Fibrosis by Artificial Intelligence Algorithm-Based Multislice Spiral Computed Tomography
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
- The value of AI-based analysis of fractional flow reserve of volume computed tomographically detected coronary artery stenosis with regard to their hemodynamic relevance
- COVID-19 in Individuals with Chronic Liver Diseases
- Clinical Overview of Sarcopenia, Frailty, and Malnutrition in Patients With Liver Cirrhosis
- Recruitment or activation of mast cells in the liver aggravates the accumulation of fibrosis in carbon tetrachloride-induced liver injury
- Alcohol use disorders and liver fibrosis: an update
- Resmetirom, the long-awaited first treatment for metabolic dysfunction-associated steatohepatitis and liver fibrosis?
- Liver cirrhosis in a patient with alcohol dependence and autoimmune hepatitis
- Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC)
- Shortness of breath due to portopulmonary hypertension and hepatopulmonary syndrome: diagnostic challenges and complex management approach in frail patients
- Use and performance of artificial intelligence applications in the diagnosis of chronic apical periodontitis based on cone beam computed tomography imaging
- Progress of mesenchymal stem cells (MSCs) & MSC-Exosomes combined with drugs intervention in liver fibrosis
- Liver fibrosis is associated with left ventricular remodeling: insight into the liver-heart axis
- Muscle Quality as a Potential Diagnostic Marker of Advanced Liver Fibrosis in Patients with Non-alcoholic Fatty Liver Disease
- The diagnostic utility of FIB-4 as a non-invasive tool for liver fibrosis scoring among NAFLD patients: a retrospective cross-sectional study
- Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis
- A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry
- A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry
- Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study
- Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study
- From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences
- Non-invasive visualization of liver fibrosis with [68Ga]Ga-DOTA-FAPI-04 PET from preclinical insights to clinical translation
- Association between the cardiometabolic index and NAFLD and fibrosis
- Angiocrine signaling in sinusoidal homeostasis and liver diseases
- Associations of dietary sugars with liver stiffness in Latino adolescents with obesity differ on PNPLA3 and liver disease severity
- Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis
- Landscape of extrachromosomal circular DNAs, transcriptome, and proteome analysis reveals insights into alcoholic liver cirrhosis
- Software with artificial intelligence-derived algorithms for analysing CT brain scans in people with a suspected acute stroke: a systematic review and cost-effectiveness analysis
- The Influence of Emodin Succinyl Ethyl Ester on Non-Alcoholic Steatohepatitis Induced by a Diet High in Fructose, Cholesterol, and Fat in Mice
- Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead
- The role of PI3k/AKT signaling pathway in attenuating liver fibrosis: a comprehensive review
- Multiscale 3D genome organization underlies duck fatty liver with no adipose inflammation or serious injury
- H2FPEF Scores Are Increased in Patients with NASH Cirrhosis and Are Associated with Post-liver Transplant Heart Failure
- Automated Prediction of Proximal Middle Cerebral Artery Occlusions in Noncontrast Brain Computed Tomography
- Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD
- Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD
- Independent Associations of Aortic Calcification with Cirrhosis and Liver Related Mortality in Veterans with Chronic Liver Disease
- Inflammatory liver diseases and susceptibility to sepsis
- Inverse association between plasma chlordecone concentrations and progression of alcoholic liver fibrosis: the role of liver metabolism
- Primary Hepatic Melanoma: A Diagnostic Surprise
- Using artificial intelligence to study atherosclerosis from computed tomography imaging: A state-of-the-art review of the current literature
- Using artificial intelligence to study atherosclerosis from computed tomography imaging: A state-of-the-art review of the current literature
- Chronic exposure to ambient air pollution and the risk of non-alcoholic fatty liver disease: A cross-sectional study in Taiwan and Hong Kong
- Hepatic extracellular ATP/adenosine dynamics in zebrafish models of alcoholic and metabolic steatotic liver disease
- Clinical review and literature analysis of hepatic epithelioid angiomyolipoma in alcoholic cirrhosis: A case report
- Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus
- The protective effects of Ninjin'yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse
- Artificial Intelligence in Nuclear Cardiology: An Update and Future Trends
- Sarcopenia in cirrhosis: Unraveling the prevalence and relationships with liver disease severity and complications
- Sarcopenia in cirrhosis: Unraveling the prevalence and relationships with liver disease severity and complications
- Associations of perfluoroalkyl substances with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2017-2018
- Identifying competing endogenous RNA regulatory networks and hub genes in alcoholic liver disease for early diagnosis and potential therapeutic target insights
- NAGNN: Classification of COVID-19 based on neighboring aware representation from deep graph neural network
- Serum miR‑29 is increased in mice with early liver fibrosis
- MRI-only based material mass density and relative stopping power estimation via deep learning for proton therapy: a preliminary study
- The transcription factor ZNF469 regulates collagen production in liver fibrosis
- The double roles of T cell-mediated immune response in the progression of MASLD
- Spleen volume is independently associated with non-alcoholic fatty liver disease, liver volume and liver fibrosis
- Author's reply: The importance of professional training to foster the implementation of Artificial Intelligence in the clinical setting of liver diseases
- Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population
- Imbalance of mitochondrial fusion in peripheral blood mononuclear cells is associated with liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis
Evidence Blueprint
Diagnosis of Liver Cirrhosis and Liver Fibrosis by Artificial Intelligence Algorithm-Based Multislice Spiral Computed Tomography
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Diagnosis of Liver Cirrhosis and Liver Fibrosis by Artificial Intelligence Algorithm-Based Multislice Spiral Computed Tomography
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests
- Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- The Value of Liver Biopsy and Histology in Liver Disease Diagnosis and Patient Care-a Pragmatic Prospective Clinical Practice Study
- Association between Liver MRI Proton Density Fat Fraction and Liver Disease Risk
- FIB-4 and APRI for cirrhosis detection in a privately insured national cohort
- Alcoholic liver disease - 2023
- NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: a multi-center, retrospective study
- EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
- The value of AI-based analysis of fractional flow reserve of volume computed tomographically detected coronary artery stenosis with regard to their hemodynamic relevance
- Validation of computed tomography as a diagnostic tool in guinea pigs with non-alcoholic fatty liver disease
- Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
- Application of artificial intelligence techniques for non-alcoholic fatty liver disease diagnosis: A systematic review (2005-2023)
- Liver fibrosis screening, evaluation pathway, and management in patients with fatty liver
- COVID-19 in Individuals with Chronic Liver Diseases
- Performance of FibroScan in grading steatosis and fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis
- Gallic acid improves liver cirrhosis by reducing oxidative stress and fibrogenesis in the liver of rats induced by bile duct ligation
- Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome
- Clinical Overview of Sarcopenia, Frailty, and Malnutrition in Patients With Liver Cirrhosis
- Liver fat as risk factor of hepatic and cardiometabolic diseases
- Higher ultra-processed food intake is associated with adverse liver outcomes: a prospective cohort study of UK Biobank participants
- Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants
- Recruitment or activation of mast cells in the liver aggravates the accumulation of fibrosis in carbon tetrachloride-induced liver injury
- First UK spine fracture patients identified by NHS-X and Nanox.AI Artificial Intelligence research study
- Alcohol use disorders and liver fibrosis: an update
- How non-alcoholic fatty liver disease and cirrhosis affect the heart
- Resmetirom, the long-awaited first treatment for metabolic dysfunction-associated steatohepatitis and liver fibrosis?
- Liver cirrhosis in a patient with alcohol dependence and autoimmune hepatitis
- Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC)
- Liver fibrosis scores and prostate cancer risk and mortality in the Atherosclerosis Risk in Communities (ARIC) Study
- Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice
- Identification of differentially methylated regions associated with both liver fibrosis and hepatocellular carcinoma
- Efficacy of Yttrium-90 Transarterial Radioembolisation in Advanced Hepatocellular Carcinoma: An Experience With Hybrid Angio-Computed Tomography and Glass Microspheres
- Progress in the Correlation Between Inflammasome NLRP3 and Liver Fibrosis
- Shortness of breath due to portopulmonary hypertension and hepatopulmonary syndrome: diagnostic challenges and complex management approach in frail patients
- Cause-specific mortality in patients with alcohol-related liver disease in Denmark: a population-based study
- Systematic review and meta-analysis: Association between liver fibrosis and subclinical atherosclerosis in nonalcoholic fatty liver disease
- Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics
- A Rare Type of Hepatocellular Carcinoma Presenting With Cardiac Thrombus
- Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019
- Use and performance of artificial intelligence applications in the diagnosis of chronic apical periodontitis based on cone beam computed tomography imaging
- Progress of mesenchymal stem cells (MSCs) & MSC-Exosomes combined with drugs intervention in liver fibrosis
- Liver fibrosis is associated with left ventricular remodeling: insight into the liver-heart axis
- Associations of severe liver diseases with cataract using data from UK Biobank: a prospective cohort study
- Muscle Quality as a Potential Diagnostic Marker of Advanced Liver Fibrosis in Patients with Non-alcoholic Fatty Liver Disease
- The diagnostic utility of FIB-4 as a non-invasive tool for liver fibrosis scoring among NAFLD patients: a retrospective cross-sectional study
- Osr1-mediated mesothelial transition of liver mesenchymal cells exacerbates fibrotic liver damage
- Extracellular Vesicles and Fatty Liver
- Serum biomarkers predictive of cirrhosis in alcoholic liver disease as an alternative to ARFI-SW elastography
- Biomarkers of liver diseases
- Research progress of celastrol on the prevention and treatment of metabolic associated fatty liver disease
- Multiple Dimensions of using Mesenchymal Stem Cells for Treating Liver Diseases: From Bench to Beside
- Fatty liver is associated with significant liver inflammation and increases the burden of advanced fibrosis in chronic HBV infection
- Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis
- Enhanced non-alcoholic fatty liver detection: Computed tomography scan image analysis and noise reduction with morphological dilation
- A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry
- A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry
- Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease
- Identifying a distinct fibrosis subset of NAFLD via molecular profiling and the involvement of profibrotic macrophages
- Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
- Trends of hospitalisation for patients with liver cirrhosis in Ningxia, China: a cross-sectional study
- Runx2 activates hepatic stellate cells to promote liver fibrosis via transcriptionally regulating Itgav expression
- Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study